Geographic distribution of hematopoietic cancers in the nile delta of Egypt

Annals of Oncology

Volumn 23, Issue 10, 2012, Pages 2748-2755

  Herzog, C M ^a   Dey, S ^b   Hablas, A ^c   Khaled, H M ^d   Seifeldin, I A ^c   Ramadan, M ^c   El Hamzawy, H ^c   Wilson, M L ^a   Soliman, A S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^c Tanta Cancer Center and the Gharbiah Population Based Cancer Registry   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Egypt; Hematopoietic cancer; Hodgkin's lymphoma; Incidence; Non Hodgkin's lymphoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; EGYPT; FEMALE; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; RURAL AREA; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; URBAN AREA; URBAN RURAL DIFFERENCE;

EID: 84867136960     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds079     Document Type: Article

References (59)

1. Robbins SL, Kumar V, Cotran RS. Robbins and Cotran Pathologic Basis of Disease. Philadelphia, PA: Elsevier 2010.
2. Parkin DM, Whelan SL, Ferlay J et al. Cancer Incidence in Five Continents, Vol. 8. Lyon, France: International Agency for Research on Cancer 2002.
3. Boyle P, Levin B. (eds), World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer 2008.
4. Freedman LS. National Cancer Institute, Middle East Cancer Consortium. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. 2006; NIH Pub. No. 06-5873. Bethesda, MD: 150.
5. Curado MP, Edwards B, Shin HR et al. (eds), Cancer Incidence in Five Continents, Vol. 9. Lyon, France: International Agency for Research on Cancer 2007; 101.
6. Soliman AS, Boffetta P. Lymphoma and leukemia. In Freedman LS, Edwards BK, Ries LAG, Young JL. (eds): Cancer Incidence in the Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC). Bethesda, MD: National Cancer Institute 2006; 131-140.
7. Mokhtar N, Gouda I, Adel I. Cancer Pathology Registry 2003-2004 and Time Trend Analysis. Cairo, Egypt: National Cancer Institute, Cairo University 2007.
8. Abdel-Fattah MM, Yassine OG. Non-Hodgkin's lymphomas in Alexandria, Egypt; incidence rates and trend study (1995-2004). Eur J Cancer Prev 2007; 16: 479-485; doi:10.1097/01.cej.0000243858.91642.c9.
9. Soliman AS, Smith MA, Cooper SP et al. Serum organochlorine pesticide levels in patients with colorectal cancer in Egypt. Arch Environ Health 1997; 52: 409-415; doi:10.1080/00039899709602219.
10. Soliman AS, Wang X, DiGiovanni J et al. Serum organochlorine levels and history of lactation in Egypt. Environ Res 2003; 92: 110-117.
11. Kriegel AM, Soliman AS, Zhang Q et al. Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt. Environ Health Perspect 2006; 114: 113-119.
12. Soliman AS, Wang X, Stanley JD et al. Geographical clustering of pancreatic cancers in the Northeast Nile Delta region of Egypt. Arch Environ Contam Toxicol 2006; 51: 142-148; Published on 20060201. doi:10.1007/s00244-005-0154-0.
13. Dey S, Soliman AS, Hablas A et al. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat 2010; 120: 149-160; Published on 20090623. doi:10.1007/ s10549-009-0427-9.
14. Dey S, Hablas A, Seifeldin IA et al. Urban-rural differences of gynecological malignancies in Egypt (1999-2002). BJOG 2010; 117: 348-355; Published on 20091216. doi:10.1111/j.1471-0528.2009.02447.x.
15. Dey S, Soliman AS, Hablas A et al. Urban-rural differences in breast cancer incidence in Egypt (1999-2006). Breast 2010; 19: 417-423; Published on 20100508. doi:10.1016/j.breast.2010.04.005.
16. Lehman EM, Soliman AS, Ismail K et al. Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry. Hepatol Res 2008; 38: 465-473; Published on 20071127. doi:10.1111/j.1872-034X.2007. 00299.x.
17. Felix AS, Soliman AS, Khaled H et al. The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 2008; 19: 421-429; Published on 20080110. doi:10.1007/s10552-007-9104-7.
18. Fedewa SA, Soliman AS, Ismail K et al. Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol 2009; 33: 176-181; Published on 20090916. doi:10.1016/j.canep.2009.08.008.
19. Soliman AS, Hung CW, Tsodikov A et al. Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt. Hepatol Int 2010; 4: 681-690; Published on 20100819. doi:10.1007/s12072-010-9187-1.
20. The Census of Egypt and Statistical Year Book, 3rd edition. Cairo, Egypt: Central Agency for Public Mobilization and Statistics (CAPMAS) 2011; http://www.capmas.gov.eg/faq.aspx?lang=2.
21. Fritz A, Percy C, Jack A et al. (eds), International Classification of Diseases for Oncology Geneva, Switzerland: World Health Organization.
22. Shipp MA, Harrington DP, Anderson JR et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994; doi:10.1056/ NEJM199309303291402.
23. Sant M, Allemani C, Tereanu C et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010; 116: 3724-3734; Published on 20100727. doi:10.1182/blood-2010-05-282632.
24. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer 2010; http://globocan.iarc.fr (1 February 2012, date last accessed).
25. United Nations, Economic Commission for Africa, Subregional Office for North Africa. Economic and Social Conditions in North Africa, Part III: The Economic Participation of Women in North Africa. http://www.uneca.org/na/Women.pdf (29 March 2012, date last accessed). 2005.
26. Smith A, Roman E, Howell D et al. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol 2010; 148: 739-753; Published on 20091201. doi:10.1111/j.1365-2141.2009.08010.x.
27. Smith A, Howell D, Patmore R et al. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 2011; 105: 1684-1692; Published on 20111101. doi:10.1038/ bjc.2011.450; 10.1038/bjc.2011.450.
28. Hartge P, Wang SS, Bracci PM et al. Non-Hodgkin's Lymphoma In: Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention New York: Oxford University Press 2009; 898-918.
29. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 67, Human Immunodeficiency Viruses and Human t-cell lymphotropic viruses. Geneva, Switzerland: IARCPress 1996.
30. Armstrong BK, Kricker A. Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 396-400; Published on 20070302. doi:10.1158/1055-9965.EPI-06-1068.
31. Boffetta P, de Vocht F. Occupation and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 369-372; doi:10.1158/1055-9965.EPI-06-1055.
32. Linet MS, Schubauer-Berigan MK, Weisenburger DD et al. Chronic lymphocytic leukemia: an overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol 2007; 139: 672-686; doi:10.1111/j.1365-2141.2007.06847.x.
33. Larson RA, Le Beau MM. Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapyrelated myeloid neoplasm. Mediterr J Hematol Infect Dis 2011; 3: e2011032. Published on 20110708. doi:10.4084/MJHID.2011.032.
34. Leone G, Fianchi L, Voso MT. Therapy-related myeloid neoplasms. Curr Opin Oncol 2011; 23: 672-680; doi:10.1097/CCO.0b013e32834bcc2a.
35. Bari A, Marcheselli L, Marcheselli R et al. Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors. Mediterr J Hematol Infect Dis 2011; 3: e2011065. Published on 20111220. doi:10.4084/MJHID.2011.065.
36. Eichenauer DA, Engert A. Therapy-related myeloid neoplasms in patients treated for hodgkin lymphoma. Mediterr J Hematol Infect Dis 2011; 3: e2011046. Published on 20111024. doi:10.4084/MJHID.2011.046.
37. Zhou Y, Tang G, Medeiros LJ et al. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Mod Pathol 2011; 25: 237-245; doi:10.1038/modpathol.2011.158; 10.1038/modpathol.2011. 158.
38. Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and metaanalysis. Int J Cancer 2009; 124: 690-697; doi:10.1002/ijc.23937.
39. Cowgill KD, Loffredo CA, Eissa SA et al. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol 2004; 33: 1034-1039; Published on 20040520. doi:10.1093/ije/dyh183.
40. Goldman L, Ezzat S, Mokhtar N et al. Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 2009; 20: 981-987; Published on 20090305. doi:10.1007/s10552-009-9316-0.
41. Gouda I, Nada O, Ezzat S et al. Immunohistochemical detection of hepatitis C virus (genotype 4) in B-cell NHL in an Egyptian population: correlation with serum HCV-RNA. Appl Immunohistochem Mol Morphol 2010; 18: 29-34; doi:10.1097/PAI.0b013e3181ae9e82.
42. Egypt National Cancer Registry. Aswan Profile-2008 2010Cairo, Egypt: Egypt National Cancer Registry; RR1.
43. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100, Part B: Biological Agents. Geneva, Switzerland: WHO Press 2009.
44. Mazzaro C, Tirelli U, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis 2005; 37: 219-226; doi:10.1016/j. dld.2005.01.003.
45. Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol 2007; 60: 1378-1383; doi:10.1136/jcp.2007.051870.
46. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int 2009; 76: 818-824; Published on 20090715. doi:10.1038/ ki.2009.247.
47. Hjalgrim H, Ekstrom-Smedby K, Rostgaard K et al. Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1561-1566; doi:10.1158/1055-9965.EPI-07-0094.
48. Morton LM, Hartge P, Holford TR et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005; 14: 925-933; doi:10.1158/1055-9965.EPI-04-0693.
49. Zahm SH, Weisenburger DD, Holmes FF et al. Tobacco and non-Hodgkin's lymphoma: combined analysis of three case-control studies (United States). Cancer Causes Control 1997; 8: 159-166.
50. Adami J, Nyren O, Bergstrom R et al. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 1998; 9: 49-56.
51. Miligi L, Seniori Costantini A, Crosignani P et al. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med 1999; 36: 60-69.
52. Willett EV, Smith AG, Dovey GJ et al. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2004; 15: 771-780; doi:10.1023/B:CACO.0000043427.77739.60.
53. Freedman DS, Tolbert PE, Coates R et al. Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men. Am J Epidemiol 1998; 148: 833-841.
54. Stagnaro E, Tumino R, Parodi S et al. Non-Hodgkin's lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004; 13: 431-437.
55. Talamini R, Polesel J, Montella M et al. Smoking and non-Hodgkin lymphoma: casecontrol study in Italy. Int J Cancer 2005; 115: 606-610; doi:10.1002/ijc.20891.
56. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2009: Implementing Smoke-Free Environments. Geneva, Switzerland: WHO Press 2009.
57. Khan AAM, Dey S, Taha AH et al. Attitudes of Cairo University medical students toward smoking: the need for tobacco control programs in medical education. J Egypt Public Health Assoc 2012; 871-21-7.
58. Mozaheb Z, Aledavood A, Farzad F. Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiol 2011; 35: 26-29; Published on 20101030. doi:10.1016/j.canep.2010.09.009.
59. Yoon SO, Suh C, Lee DH et al. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 2010; 85: 760-764; doi:10.1002/ ajh.21824.